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Abstract
We have investigated the interactions and consequences of superinfecting and coreplication of human papillomavirus (HPV) and herpes
simplex virus (HSV) in human epithelial organotypic (raft) culture tissues. In HPV-positive tissues, HSV infection and replication induced
significant cytopathic effects (CPE), but the tissues were able to recover and maintain a certain degree of tissue integrity and architecture.
HPV31b not only maintained the episomal state of its genomic DNA but also maintained its genomic copy number even during times of
extensive HSV-induced CPE. E2 transcripts encoded by HPV31b were undetectable even though HPV31b replication was maintained in
HSV- infected raft tissues. Expression of HPV31b oncogenes (E6 and E7) was also repressed but to a lesser degree than was E2 expression.
The extent of CPE induced by HSV is dependent on the magnitude of HPV replication and gene expression at the time of HSV infection.
During active HSV infection, HPV maintains its genomic copy number even though genes required for its replication were repressed. These
studies provide new insight into the complex interaction between two common human sexually transmitted viruses in an in vitro system,
modeling their natural host tissue in vivo.
© 2003 Elsevier Inc. All rights reserved.
Introduction
Worldwide, cervical cancer is the third most prevalent
female cancer. Between 400,000 and 500,000 new cases are
reported each year with nearly 200,000 deaths (Bai et al.,
2000; Mohar and Frias-Mendivil, 2000). Human papilloma-
viruses (HPV) have been associated with over 90% of all
cervical cancers examined and they are considered the most
important risk factor (Broker and Botchan, 1986; Pfister,
1987b; zur Hausen and Schneider, 1987). Infection with
HPV is necessary but not sufficient for the development of
cervical cancer. It is hypothesized that HPV infection leads
to the transformation and the subsequent expression of the
malignant phenotype that influences the deregulation of the
proliferating cell. This is a multistep process and the long
period of latency from the initial time of infection to the
development of disease suggests that other determinants
may be involved as possible cofactors in the pathogenesis of
HPV-related genital cancers. These include smoking (Brock
et al., 1989), steroid hormones (Brinton, 1991; Brinton et
al., 1990; Thomas, 1991a; WHO Collaborative Study,
1993), herpes simplex virus type 2 (HSV-2) (Jones, 1995;
zur Hausen, 1982), human cytomegalovirus (Jones, 1995),
human herpesvirus 6 (Chen et al., 1994; Del Vecchio et al.,
1992; DiPaolo et al., 1993), human immunodeficiency virus
(Vernon et al., 1992, 1993, 1994a, 1994b), and chlamydia
(Anttila et al., 2001; Koskela et al., 2000; Smith et al., 2002;
Tamim et al., 2002).
Of particular interest is the association of HSV with HPV
and cervical carcinogenesis. HSV-2 is transmitted sexually
(similar to HPV) and can cause recurrent, painful ulcers
(Sherman et al., 1991). Since HSV and HPV are transmitted
sexually and infect the same cell type, both viruses have the
potential to interact with each other, impacting neoplastic
progression. Additionally, epidemiological studies on the
association of cervical carcinoma with HPV and HSV have
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been reported (Di Luca et al., 1987, 1989; Eglin et al., 1981;
Hildesheim et al., 1991; Macnab et al., 1986; Manservigi et
al., 1986; McDougall et al., 1980, 1984; Olsen et al., 1998;
Prakash et al., 1985; Rotola et al., 1986; Smith et al., 2002).
Initially in the pathogenesis of HSV the virus infects and
replicates at the mucosal or epidermal surfaces, and HSV is
subsequently transported to the ganglia where it replicates
and then becomes latent. The development of the organo-
typic epithelial culture system has provided a potentially
powerful tool for the study of infectious agents that infect
the epithelium. Previously we have demonstrated the facil-
ity of this system to study the replication and pathogenesis
of HPV (Bromberg-White and Meyers, 2002; Mayer and
Meyers, 1998; Meyers et al., 1992b; Ozbun and Meyers,
1996, 1997, 1998a, 1999b; Sen et al., 2002; Southern et al.,
2001) and HSV (Visalli et al., 1997). In this present article
we report the use of the organotypic epithelial raft culture
system to investigate the interactions of two important hu-
man sexually transmitted viruses, HPV and HSV. The use
of organotypic raft cultures is the only in vitro system that
can provide a tissue culture system that will enable the
complete replication cycle of both viruses.
Results
Cytopathic effects and spread of HSV-1 (KOS) and HSV-2
(186) in organotypic HPV-positive epithelial culture
tissues
HPV-positive CIN-612 9E organotypic (raft) culture tis-
sues were assayed for their ability to support HSV infection.
CIN-612 9E raft tissues were allowed to grow and differ-
entiate for 3, 6, or 9 days at the air–liquid interface and then
were infected by application of 103 plaque-forming units
(PFU) of either HSV-1 (KOS) or HSV-2 (186) to the top of
the tissue. Raft tissues grown for 3, 6, and 9 days were used
to study HSV infection of tissues which had stratified and
differentiated to different extents with concomitant differ-
ences in the progress of the HPV life cycle. Mock-infected
tissues were also included.
Tissues infected with HSV following 3 days of growth
and differentiation at the air–liquid interface were harvested
as described under Materials and methods for histological
examinations. Hematoxylin and eosin staining was done to
examine the effect of HSV infection on the HPV-positive
epithelial morphology (Fig. 1). Changes in the normal CIN-
612 9E morphology were clearly seen 24 h post-infection
with both HSV-1 (KOS) and HSV-2 (186) (Figs. 1A, F, and
K). Evidence of HSV-induced cytopathic effects (CPE) is
visible 24 h post-HSV infection and increases until the
tissue was completely decimated 5 days post-infection
(Figs. 1E, J, and O), whereas mock-infected tissue displayed
a morphology representative of CIN-612 9E raft tissues
(Mayer et al., 2000; Mayer and Meyers, 1998; Meyers et al.,
1992; Ozbun and Meyers, 1996, 1997). Tissues examined at
time periods greater than 5 days post-HSV infection (data
not shown) remained devoid of tissue, suggesting that in-
fection with HSV-1 or HSV-2 was capable of completely
destroying the HPV-positive CIN-612 9E raft culture tis-
sues. These results are similar to what we previously ob-
served when we infected HPV-negative raft culture tissues
with HSV-1 or HSV-2 (Visalli et al., 1997). HPV-negative
raft culture tissues infected with HSV-1 or HSV-2 at any
time point following the lifting of the raft culture to the
air–liquid interface for growth and differentiation resulted
in active HSV replication and total tissue decimation within
3 days of HSV infection of the tissues (Visalli et al., 1997).
Thin sections of HPV-positive CIN-612 9E raft tissues
infected with HSV were immunohistochemically analyzed
to determine the location and spread of HSV-1 and HSV-2
within the epithelial architecture (Fig. 2). An HSV ICP4
polyclonal antibody was used to identify cells that were
undergoing the early stages of HSV replication events (Figs.
2A–J). As early as 24 h post-HSV infection, some nuclei of
the basal cell layer showed an ICP4-positive staining in both
HSV-1 (KOS) and HSV-2 (186) infected tissues (Figs. 2A
and F). Expression of ICP4 increased with time, whereas
mock-infected tissue was negative for ICP4 expression at all
time points (data not shown). Similar kinetics of ICP4
expression was previously obtained when we infected pri-
mary keratinocyte raft cultures HSV (Visalli et al., 1997).
To identify cells within the epithelial cross sections that
were undergoing late stages of the HSV life cycle, we used
a monoclonal antibody to the HSV major capsid polypep-
tide, VP5 (Fig. 2K–T). Similar to the expression of ICP4 in
the HSV-infected tissues, VP5 expression was observed as
early as 24 h post-HSV infection (Figs. 2K and P). How-
ever, VP5 expression increased to a greater level with time
than what was observed for ICP4, suggesting a steady in-
crease in the synthesis of the major capsid polypeptide of
HSV-1 and HSV-2. Again, mock-infected tissues were uni-
formly negative for VP5 expression at all time points (data
not shown).
From these initial studies we concluded that infecting
HPV-positive raft tissues after 3 days of growth and differ-
entiation at the air–liquid interface led to HSV replication
and spread, CPE, and complete destruction of the tissue.
Our next set of experiments was then designed to determine
if the stage of the HPV life cycle had an effect on HSV
infection. Based on our previous studies describing HPV
gene expression (Mayer and Meyers, 1998; Ozbun and
Meyers, 1996, 1997, 1998a, 1999a,b), HSV-1 (KOS) or
HSV-2 (186) was added to the CIN-612 9E raft cultures at
two particular stages of the HPV life cycle. Three days of
growth and differentiation at the air–liquid interface repre-
sents a time when HPV gene expression is at a low point but
just beginning to increase in preparation for viral replica-
tion. Six days of growth and differentiation at the air–liquid
interface represents a time when HPV gene expression is at
a midpoint in its linear logarithmic increase and is just at the
boundary associated with maximum virion synthesis. Nine
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days of growth and differentiation at the air–liquid interface
represents a time when HPV gene expression has reached its
plateau and maximum virion synthesis is occurring. Having
previously infected HPV-positive raft tissue with HSV after
3 days of growth, when HPV gene expression is low, we
decided to test the effect of infecting with HSV after 6 and
9 days of growth when HPV gene expression is significantly
higher.
We therefore performed the same set of experiments but
infecting CIN-612 9E raft tissue with HSV-1 (KOS) and
HSV-2 (186) on the sixth day of growth and differentiation
at the air–liquid interface. Raft cultures were harvested 1, 2,
3, 4, and 5 days post-HSV infection and thin sections were
prepared and stained with hematoxylin and eosin to exam-
ine tissue morphology. Similar to CIN-612 9E (HPV31b)
raft cultures grown for 3 days and then infected with HSV,
HPV- positive cultures were grown for 6 days and infected
with HSV and exhibited progressive tissue destruction over
the first 5 days following HSV infection (Fig. 3). Mock-
infected HPV-positive CIN-612 9E raft tissues grew and
differentiated with similar kinetics and morphology as pre-
viously observed for CIN-612 9E raft tissues (Figs. 3A–F)
(Mayer et al., 2000; Mayer and Meyers, 1998; Meyers et al.,
1992b; Ozbun and Meyers, 1996, 1997). We then asked if
the HSV-infected CIN-612 9E (HPV31b) tissues could con-
tinue to grow past day 5 post-HSV infection or would the
tissue be eventually destroyed as seen previously in tissues
that only grew for 3 days at the air–liquid interface before
being infected with HSV (compare Figs. 1 and 3). In con-
trast to raft tissue infected on the third day of growth at the
air–liquid interface, tissues infected with HSV following 6
days of growth at the air–liquid interface recovered from the
destruction elicited by the infection and replication of
HSV-1 (KOS) and HSV-2 (186) (Fig. 3).
To determine the location and spread of HSV-1 and
HSV-2 within the raft epithelial cells, we performed immu-
nohistochemistry analysis to visualize the expression of the
HSV ICP4 and VP5 (Fig. 4). The continued presence of
VP5 strongly suggests that the virus was still present in the
tissues (Figs. 5O and T).
To further examine the long-term effects of the HSV infec-
tions on HPV-positive tissues, CIN-612 9E tissues infected
with HSV after growth for 6 days at the air–liquid interface
were harvested at 8, 10, 12, 14, and 16 days post-HSV infec-
tion, sectioned, and stained with hematoxylin and eosin. The
tissue displayed CPE due to the HSV infection but was never
completely destroyed (Fig. 5). Pictures of mock-infected tis-
sues 12 and 16 days p.i. are included in Figs. 5F and L for
comparison. The tissue appeared to go through cycles of high
levels of CPE and then would recover before another round of
high CPE. ICP4 and VP5 were expressed throughout the time
period investigated, suggesting that HSV replication was con-
tinuous (Fig. 6).
HPV-positive CIN-612 9E raft cultures were allowed to
grow and differentiate for 9 days at the air–liquid interface
before infection with HSV-1 (KOS) or HSV-2 (186) gave
results similar to those seen in cultures grown for 6 days at
the air–liquid interface and then were infected with HSV
(data not shown). Additionally, infecting the HPV-positive
tissues with only 102 PFU of HSV-1 (KOS) or HSV-2 (186)
produced similar results as using 103. PFU of HSV for
infection, except for slightly slower kinetics of CPE devel-
opment and the expression of ICP4 and VP5 (data not
shown).
Replication kinetics of HSV-1 (KOS) and HSV-2 (186) in
organotypic HPV-positive epithelial culture tissues
To more directly demonstrate the ability of HPV-positive
organotypic tissues to support HSV replication, HSV titra-
tions were performed. HPV-positive CIN-612 9E raft cul-
ture tissues were allowed to grow and differentiate for 6 and
9 days at the air–liquid interface and then 102 or 103 PFU of
either HSV-1 (KOS) or HSV-2 (186) was applied to the top
of the epithelial tissue. Tissues were harvested at 24-h
periods post-HSV infection as described under Materials
and methods. Virus titrations were performed using Vero
cells at each time point and the data were tabulated and
graphed as total PFU per infected organotypic culture (Fig.
7). HSV infections exhibited typical eclipse and logarithmic
viral infection phases followed by a steady decrease in the
HSV titer. After longer incubation times relatively low titers
of HSV-1 (KOS) and HSV-2 (186) were maintained with
fluctuations of a log or two in the total amount of virus per
raft tissues that correlated with the levels of the viral pro-
teins, ICP4 and VP5, and with the state of the tissue CPE.
Titers appeared higher immediately preceding time periods
when the greatest CPE was observed.
State of the HPV DNA in the HSV-infected tissue
Previous studies have shown a strong association of HPV
DNA integration into the host genome with cervical malig-
nancy (Jeon et al., 1995; Jeon and Lambert, 1995). These
studies strongly suggested that integration of HPV DNA
into the host chromosomes can be an important milestone in
the progression of cervical cancer. We have hypothesized
that if HSV infection occurs during a specific stage in the
HPV life cycle, then HSV has the potential to act as a
cofactor and influence progression to cervical cancer possi-
bly by inducing the integration of HPV genomic DNA into
the host chromosomes. To test this hypothesis, we examined
the status of HPV DNA at various times post-HSV infec-
tion. Total cellular and viral DNA was isolated and analyzed
by Southern blot hybridization. Differences in HPV
genomic copy number between mock-infected and HSV-
infected HPV-positive raft tissues were then approximated
by comparisons with copy number controls (Fig. 8).
HPV-positive CIN-612 9E raft cultures were allowed to
grow and differentiate for 6 or 9 days and then were infected
with 103 or 102 PFU of HSV-1 (KOS) or HSV-2 (186). Raft
grown tissues were allowed to grow for another 2, 4, 6, and
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Fig. 1. Hematoxylin and eosin staining of herpes simplex virus (HSV) infected HPV31b-positive CIN-612 9E organotypic raft culture tissues. CIN-612 9E
raft culture tissues were allowed to grow and differentiate for 3 days at the air–liquid interface and then were mock-infected (A–E), infected with HSV-1
(KOS) (F–J), or infected HSV-2 (186) (K–O). To each tissue 10 PFU of virus were applied as described under Materials and methods. Infected tissues were
incubated at 37°C harvested at 24-h time periods post-HSV infection, and fixed in 10% buffered formalin. Thin sections of tissue from each time point
postinfection (pi) were stained with hematoxylin and eosin. (A, F, K) 1 day (1d) pi; (B, G, L) 2 days pi; (C, H, M) 3 days pi; (D, I, N) 4 days pi; and (E,
J, O) 5 days pi.
Fig. 2. Immunostaining of herpes simplex virus (HSV) infected HPV31b-positive CIN-612 9E organotypic raft culture tissues. CIN-612 9E raft culture tissues
were allowed to grow and differentiate for 3 days at the air–liquid interface and then were infected with HSV-1 (KOS) (A–E and K–O) or infected HSV-2
(186) (F–J and P–T). To each tissue 103 PFU of virus were applied as described under Materials and methods. Infected tissues were incubated at 37°C
harvested at 24 h time periods post-HSV infection, and fixed in 10% buffered formalin. Thin sections of tissue from each time point postinfection (pi) were
immunostained with an HSV-1 ICP4 monoclonal antibody (A–J) or a monoclonal antibody to the HSV major capsid polypeptide, VP5 (K–T). (A, F, K, P)
1 day (1d) pi; (B, G, L, Q) 2 days pi; (C, H, M, R) 3 days pi; (D, I, N, S) 4 days pi; and (E, J, O, T) 5 days pi. Areas staining black represent positive staining
for the HSV proteins ICP4 and VP5. Arrows point to representative areas of positive staining.
Fig. 3. Hematoxylin and eosin staining of herpes simplex virus (HSV) infected HPV31b-positive CIN-612 9E organotypic raft culture tissues. CIN-612 9E raft
culture tissues were allowed to grow and differentiate for 6 days at the air–liquid interface and then were mock-infected (A–F), infected with HSV-1 (KOS) (G–L),
or infected HSV-2 (186) (M–R). To each tissue 103 PFU of virus were applied as described under Materials and methods. Infected tissues were incubated at 37°C,
harvested at 24-h time periods post-HSV infection, and fixed in 10% buffered formalin. Thin sections of tissue from each time point postinfection (pi) were stained
with hematoxylin and eosin. (A, G, M) 1 day (1d) pi; (B, H, N) 2 days pi; (C, I, O) 3 days pi; (D, J, P) 4 days pi; (E, K, Q) 5 days pi; and (F, L, R) 6 days pi.
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8 days post-HSV infection and then were harvested for
Southern blot analysis. We observed no decrease in the
levels of HPV DNA following HSV infection as compared
to mock-infected cultures (Fig. 8). In general there was an
increase in HPV genomic copy number in HSV-infected
cultures as compared to mock-infected cultures. HPV
Fig. 4. Immunostaining of herpes simplex virus (HSV) infected HPV31b-positive CIN-612 9E organotypic raft culture tissues. CIN-612 9E raft culture tissues
were allowed to grow and differentiate for 6 days at the air–liquid interface and then were infected with HSV-1 (KOS) (A–E and K–O) or infected HSV-2
(186) (F–J and P–T). To each tissue 103 PFU of virus was applied as described under Materials and methods. Infected tissues were incubated at 37°C
harvested at 24-h time periods post-HSV infection, and fixed in 10% buffered formalin. Thin sections of tissue from each time point postinfection (pi) were
immunostained with an HSV-1 ICP4 monoclonal antibody (A–J) or a monoclonal antibody to the HSV major capsid polypeptide, VP5 (K–T). (A, F, K, P)
1 day (1d) pi; (B, G, L, Q) 2 days pi; (C, H, M, R) 3 days pi; (D, I, N, S) 4 days pi; and (E, J, O, T) 5 days pi. Areas staining black represent positive staining
for the HSV proteins ICP4 and VP5. Arrows point to representative areas of positive staining.
Fig. 5. Hematoxylin and eosin staining of herpes simplex virus (HSV) infected HPV31b-positive CIN-612 9E organotypic raft culture tissues grown for
extended time periods post-HSV infection. CIN-612 9E raft culture tissues were allowed to grow and differentiate for 6 days at the air–liquid interface and
then were infected with HSV-1 (KOS) (A–E), infected with HSV-2 (186) (G–K), or mock- infected (F, L). To each tissue 103 PFU of virus was applied as
described under Materials and methods. Infected tissues were incubated at 37°C harvested at different times post-HSV infection, and fixed in 10% buffered
formalin. Thin sections of tissue from each time point postinfection (pi) were stained with hematoxylin and eosin. (A, G) 8 days (8d) pi; (B, H) 10 days pi;
(C, F, I) 12 days pi; (D, J) 14 days pi; and (E, K, L) 16 days pi.
Fig. 6. Immunostaining of herpes simplex virus (HSV) infected HPV31b-positive CIN-612 9E organotypic raft culture tissues grown for extended time
periods post-HSV infection. CIN-612 9E raft culture tissues were allowed to grow and differentiate for 6 days at the air–liquid interface and then were infected
with HSV-1 (KOS) (A–B) or infected HSV-2 (186) (C–D). To each tissue 103 PFU of virus was applied as described under Materials and methods. Infected
tissues were incubated at 37°C harvested at different times post-HSV infection, and fixed in 10% buffered formalin. Thin sections of tissue from each time
point postinfection (pi) were immunostained with an HSV-1 ICP4 monoclonal antibody (A–B) or a monoclonal antibody to the HSV major capsid
polypeptide, VP5 (C–D). (A, C) 8 days (8d) pi; and (B, D) 12 days pi. Areas staining black represent positive staining for the HSV proteins ICP4 and VP5.
Arrows point to representative areas of positive staining.
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genomic copy numbers fluctuated at different time points
post-HSV infection. The effect of the HSV infection was the
same whether the raft tissues were allowed to grow for 6 or
9 days at the air–liquids interface before infecting with
HSV. Additionally, in these tissues we were unable to detect
the presence of integrated HPV DNA which would have
appeared as a band just below the position of the loading
wells on the Southern blot coincident with high molecular
weight cellular DNA. This data demonstrate, at least at the
time points analyzed, that infection with either HSV-1
(KOS) or HSV-2 (186) did not affect the episomal mainte-
nance of HPV genomic DNA. Therefore, if HSV does act as
a cofactor for cervical cancer progression, it functions sep-
arately from the induction of HPV genomic integration or
requires a longer period of time to impart this effect, sug-
gesting an indirect mechanism.
The effect of HSV infection on HPV gene expression
It has been suggested that down regulation of HPV E2
expression and/or derepression of the HPV oncogenes E6
and E7 expression are important steps in the progression of
cervical cancer (Jeon et al., 1995; Jeon and Lambert, 1995;
Lambert and Howley, 1988; Romanczuk and Howley, 1992;
Schiller et al., 1989). A potential cofactor role for HSV
could therefore be an effect on the transcription of HPV
genes E2, E6, or E7. To test this, we compared the expres-
sion levels of HPV31b E2, E6, and E7 in mock-infected,
HSV-1-infected, and HSV-2-infected tissues.
To measure HPV31b E2, E6, and E7 gene expression in
mock- and HSV-infected CIN-612 9E tissues, we employed
the RNase protection assay (RPA). To quantify changes in
HPV31b E2, E6, and E7 expression following HSV infec-
tion, CIN-612 9E raft cultures were grown as described for
6 days at the air-liquid interface, and then were mock-,
HSV-1-, or HSV-2-infected, and RNA was harvested 2, 4,
or 6 days postinfection. To analyze E2 expression, RPA was
performed using a 276 nt E2- specific riboprobe, which will
result in a 169-nt protected fragment representing E2 tran-
scripts. Two days post-HSV infection we observed a de-
crease in HPV31b E2 transcript expression particularly in
tissues infected with HSV-2 as compared to mock-infected
tissues (Fig. 9). This decrease in HPV31b E2 expression
was increasingly more prominent at 4 and 6 days post-HSV
infection, for both HSV-1 (KOS) and HSV-2 (186) as com-
pared to the control mock-infected tissues. A decrease in
HPV31b transcripts utilizing the E1 splice donor is clearly
seen at 4 (Fig. 9, 6/10) and 6 days (Fig. 9, 6/12) post-HSV
infection as compared to mock- infected samples (Fig. 9).
The HPV31b E1 splice donor is predominately utilized to
create the E1^E4 (Ozbun and Meyers, 1999a, 1998a)
spliced in-frame gene and to a lesser extent the E1*I and
E1*II spliced transcripts (Ozbun and Meyers, 1999a,
1998a). This data suggest that HSV infection induces an
inhibition of HPV31b transcripts. A potential mechanism
for this HSV infection associated effect could be attributed
to the HSV virus host shutoff (vhs) gene, which inhibits host
transcription and RNA processing by destabilizing host cell
Fig. 7. HSV-infected HPV31b-positive CIN-612 9E raft tissue HSV growth curves. HPV31b-positive CIN-612 9E raft tissues were infected with 102 or 103
PFU of either HSV-1 (KOS) or HSV-2 (186) as described under Materials and methods. Raft tissues were allowed to grow and differentiate at the air–liquid
interface for 6 or 9 days before HSV was applied. HSV-infected tissues were incubated at 37°C and harvested at various times post HSV infection, and HSV
replication was titered on Vero cells as described under Materials and methods. HSV replication was graphed as total PFU per infected organotypic raft
culture.
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mRNAs (Fenwick and Walker, 1978; Hill et al., 1985;
Kwong and Frenkel, 1987; Reed and Frenkel, 1983; Schek
and Bachenheimer, 1985). What is surprising is that studies
have shown a requirement for the HPV E2 protein in the
replication (Del Vecchio et al., 1992; Frattini and Laimins,
1994; Ustav and Stenlund, 1991) and episomal maintenance
(Frattini and Laimins, 1994; Hubert et al., 1999; Ustav and
Stenlund, 1991) of the HPV genome. Our data suggests that
in the presence of a productive HSV infection, HPV E2
gene expression is not required for the replication and epi-
somal maintenance of HPV DNA.
To analyze HPV31b E6E7 oncogene expression during
coinfection with HSV-1 (KOS) and HSV-2 (186), we used
a 548-nt E6E7-specific riboprobe, which will result in a
365-nt protected fragment representing the expression of
E6E7 transcripts. Four and six days (Fig. 10, 6/10 and 6/12)
post-HSV infection, expression of E6E7 was undetectable
in the mock-infected tissues but remained detectable in
HSV-infected tissues (Fig. 10). This is in contrast with the
rapid repression of the HPV31b E2 gene, suggesting differ-
ential specificity in the kinetics and magnitude of HSV-
induced repression of HPV gene expression.
DISCUSSION
Previously we reported the facility of the organotypic
tissue culture for investigations concerning the initial infec-
tion and spread of HSV in its host tissue squamous epithe-
lium (Visalli et al., 1997). Both HSV-1 and HSV-2 followed
the standard infection kinetics in organotypic raft tissues
derived from epidermal keratinocytes and ectocervical ker-
atinocytes. We have now extended these studies to investi-
gate the interaction and consequences of superinfecting
HPV-positive raft culture tissue with HSV, mimicking a
potentially important in vivo situation. HPVs have been
associated with over 90% of all cervical cancers examined
and are considered the most important risk factor (Broker
and Botchan, 1986; Pfister, 1987a; zur Hausen and Schnei-
der, 1987). Infection with HPV is necessary but not suffi-
cient for the development of cervical cancer. It is hypothe-
sized that HPV leads to the transformation and the
subsequent expression of the malignant phenotype that in-
fluences the deregulation of the proliferating cell. This is a
multistep process and the long period of latency from the
initial time of infection to the development of malignancy
Fig. 8. Southern blot hybridization of HPV31b genomic DNA post-HSV infection in raft culture. HPV31b-positive CIN-612 9E cells were grown in raft
culture and infected with HSV-1 (KOS), HSV-2 (186), or mock-infected after 6 (6/8–6/14) and 9 days (9/11–9/17) of growth and differentiation at the
air–liquid interface as described under Materials and methods. Raft tissues were then harvested for DNA after 2 days (2d) (6/8 and 9/11) post-HSV infection
(pi); 4 days pi (6/10 and 9/13); 6 days pi (6/12 and 9/15); and 8 days pi (6/14 and 9/17). Five micrograms of total cellular DNA was digested with BamHI
(odd numbered lanes), which does not cut the HPV31b genome, and with HindIII (even numbered lanes), which cuts the HPV31b genome once linearizing
it. Restriction enzyme digests were electrophoresed, Southern blotted, and probed with an HPV31- specific probe. The lowest band indicates form I (FI,
supercoiled) HPV31b DNA (odd numbered lanes). The upper bands indicate form II (FII, relaxed circle) HPV31b DNA and dimeric HPV31b genomes (odd
numbered lanes). The middle band indicates form III (FIII, linearized) HPV31b DNA (even numbered lanes). Experiments were performed at least three
times.
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suggests that other determinants may be involved as possi-
ble cofactors in the pathogenesis of HPV-related genital
cancers. These include smoking (Brock et al., 1989), steroid
hormones (Brinton, 1991; Brinton et al., 1990; Thomas,
1991; WHO Collaborative Study, 1993), herpes simplex
virus type 2 (HSV-2) (Jones, 1995; zur Hausen, 1982),
human cytomegalovirus (Jones, 1995), human herpesvirus 6
(Chen et al., 1994; Del Vecchio et al., 1992; DiPaolo et al.,
1993), human immunodeficiency virus (Vernon et al., 1992,
1993, 1994a, 1994b), and chlamydia (Anttila et al., 2001;
Koskela et al., 2000; Smith et al., 2002; Tamim et al., 2002).
Of particular interest with regard to our present study is
the association of HSV-2 with HPV. HSV-2 infection is
transmitted sexually (similar to HPV) and can cause recur-
rent, painful genital ulcers. A recent study of HSV-2 infec-
tions in the United States concluded that since late 1970s the
prevalence of HSV-2 infections has increased 30–32%, and
HSV-2 is detectable in one of five persons 12 years of age
or older nationwide (Brugha et al., 1997). Since HSV and
HPV are transmitted sexually and infect the same cell type,
both viruses have the potential to interact with each other
and play a role in neoplastic progression. To date, there
have been no studies in which the interaction of HPV and
HSV has been studied in which both viruses could accom-
plish a complete replication cycle.
Epidemiological studies on the association of cervical
carcinoma with HPV and HSV-2 have been reported.
Women infected with HSV-2 and HPV are at a greater risk
for the development of cervical carcinoma compared to
women infected with only one virus (Hildesheim et al.,
1991). Early studies showed a prevalence of higher titers of
HSV-2-specific antibody in women who developed cervical
cancer (Rawls et al., 1976). To assess possible interactions
between HSV-2 and high-risk HPV in the pathology of
cervical carcinoma, cervical tumors were examined for the
presence of both viral DNAs (Di Luca et al., 1987, 1989). It
was reported that six of the eight cervical cancer biopsy
specimens that contained HSV-2 sequences also contained
HPV DNA.
The influence on HPV gene expression by HSV has also
been studied. Using heterologous systems, HSV-1 immedi-
ate-early transactivators such as ICP4 and ICP0 enhance
transcription of the upstream regulatory regions of HPV16
(McCusker and Bacchetti, 1988). Furthermore, HSV-1
transactivators such as VP16 and ICP0 activated HPV18
expression in a variety of cells (Gius and Laimins, 1989).
Infection with HSV-1 resulted in the amplification of bovine
papillomavirus type 1 (BPV-1) sequences (Schmitt et al.,
1989). Similar results were obtained by Hara et al. (1997)
when they used HeLa cells and A431 cells where HPV
DNA was transiently episomal following introduction by
transfection. Infection of HeLa cells with HSV-1 strongly
modified HPV gene expression by reducing the amounts of
specific mRNAs (Karlen et al., 1993). This was attributed to
Fig. 10. Ribonuclease protection analyses quantifying HPV31b E6 and E7
transcripts. HPV31b-positive CIN-612 9E raft cultures were allowed to
grow and differentiate for 6 days at the air–liquid interface and then
mock-infected, or infected with 103 PFU of HSV-1 (KOS), or HSV-2
(186). Raft tissues were then harvested for RNA after 2 days (2d) (6/8); 4
days pi (6/10); and 6 days pi (6/12) post-HSV infection. CIN-612 9E
monolayer RNA was also harvested for comparison. Ten micrograms of
DNase I treated total RNA or yeast RNA (Y) were analyzed. Location and
size of RNA Century Markers (Ambion) are shown to the left in nucleo-
tides (200, 300, and 400). Experiments were performed at least three times.
Fig. 9. Ribonuclease protection analyses quantifying HPV31b E2 and E1
splice transcripts. HPV31b-positive CIN-612 9E raft cultures were allowed
to grow and differentiate for 6 days at the air–liquid interface and then were
mock-infected, or infected with 103 PFU of HSV-1 (KOS), or HSV-2
(186). Raft tissues were then harvested for RNA after 2 days (2d) (6/8); 4
days pi (6/10); and 6 days pi (6/12) post-HSV infection. Ten micrograms
of DNase I treated total RNA or yeast RNA (Y) were analyzed. Location
and size of RNA Century Markers (Ambion) are shown to the left in
nucleotides (100 and 200). Experiments were performed at least three
times.
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a virion component, notably the virion host shutoff protein,
vhs.
Our present studies were designed to define the interac-
tion of these two sexually transmitted viruses (HPV and
HSV) using epithelial organotypic raft culture model sys-
tems. Experiments were designed to determine the level of
CPE induced by HSV infection, HSV’s ability to replicate
and spread, and HSV’s effect on HPV replication at specific
stages in the HPV life cycle. In vivo, HPV and HSV appear
to infect the same genital tissues, suggesting the possibility
that HSV acts as a cofactor in the multistep process of
HPV-associated cervical cancer. Independent of the length
of time the HPV-positive CIN-612 9E raft cultures were
allowed to grow and differentiate at the air–liquid interface,
HSV-1 (KOS) and HSV-2 (186) were able to infect the raft
tissue, induce significant CPE, and replicate. Evidence for
HSV replication was demonstrated by the expression of the
immediate-early HSV protein ICP4 and the HSV late capsid
protein VP5. Additionally, direct evidence was provided by
titering HSV directly from the infected raft tissues.
Whereas the magnitude and kinetics of HPV31b replica-
tion and gene expression did not significantly affect the
ability of HSV to replicate, it did affect the ability of the
tissue to recover from the HSV-induced CPE. HPV-positive
raft tissues were infected with HSV-1 (KOS) or HSV-2
(186) after 3, 6, or 9 days of growth and differentiation at
the air–liquid interface. HSV infection of HPV- positive raft
tissue after 3 days at the air–liquid interface resulted in
significant and complete CPE, decimating the tissue by 5
days post-HSV infection. HPV-positive raft tissues that
were infected with HSV after 6 or 9 days at the air–liquid
interface also resulted in significant CPE, but these tissues
were able to recover and maintain a certain degree of tissue
integrity and architecture. We examined the raft culture
tissue for up to 16 days post-HSV infection and the tissue
was still able to maintain a certain degree of integrity and
architecture. The tissue went through a period of significant
CPE, giving the appearance that it would succumb, but
would always recover usually within another 24 h. Expres-
sion of HSV ICP4 and VP5 protein expression accompanied
these cycles of extreme CPE and recovery. It is interesting
that the ability of the tissue to “survive” HSV infection and
CPE correlates with the increased magnitude of HPV31b
replication and gene expression occurring at days 6 and 9
during growth and differentiation. It appears that HPV is
able to elicit a survival mechanism maintaining vestiges of
the host tissues architecture for its own replication.
We directly examined the effects of HSV infection on
the HPV31b life cycle by assaying the episomal mainte-
nance and copy number of the HPV31b genome and the
expression of the HPV31b E2 and E6E7 transcripts. Inter-
estingly, HPV31b not only maintained the episomal state of
it genomic DNA but also maintained its genomic copy
number even during times of extensive HSV-induced CPE.
HSV has been hypothesized as a potential cofactor for
HPV- associated cervical carcinogenesis. One of the mile-
stones associated with the development of the carcinogenic
event is the integration of the HPV genome into the host
chromosomes. We found no evidence for the induction of
HPV genomic DNA to integrate into the host chromosomes.
This does not rule out the possibility that HSV can still
induce HPV DNA integration following greater time peri-
ods than what we have examined or that other host or
external factors are also required. Additionally, it is inter-
esting that HPV appears to maintain its ability to replicate
normally. The replication of the related small DNA virus,
SV40, following HSV superinfection adopts a large com-
plex branched structure similar to the replication of the HSV
DNA (Blumel et al., 2000).
Studies have suggested that down regulation of HPV E1
and E2 expression and/or derepression of the HPV onco-
genes E6 and E7 expression are important steps in the
progression of cervical cancer (Jeon et al., 1995; Jeon and
Lambert, 1995; Lambert and Howley, 1988; Romanczuk
and Howley, 1992; Schiller et al., 1989). A potential cofac-
tor role for HSV could therefore be an effect on the tran-
scription of HPV genes E1, E2, E6, or E7. To test this we
compared the expression levels of HPV31b E2, E6, and E7
in mock-infected, HSV-1-infected, and HSV-2-infected tis-
sues. When the steady-state levels of the HPV31b E2 tran-
script were analyzed, we observed a complete loss of ex-
pression after 6 days post-HSV infection. The requirement
for the HPV E2 gene product coupled with the E1 gene
product has been shown for HPV DNA replication to occur
(Del Vecchio et al., 1992; Ustav and Stenlund, 1991). This
result was surprising in light of the previous result where
HPV31b maintained the copy number of genomic DNA.
Because the raft tissue is constantly replenishing itself,
especially with HSV-induced CPE, HPV must continuously
replicate its genome. This would suggest that HPV31b is
able to replicate its DNA in HSV-infected raft tissues even
when E2 gene expression is repressed. When we analyzed
HPV31b oncogene expression, we observed that while ex-
pression was repressed, RNAs for E6E7 were still expressed
even after 6 days post-HSV infection.
Our studies have found no direct evidence for a role of
HSV as a cofactor in HPV-associated cervical carcinogen-
esis. Although we should point out that these studies only
examined the effect of HSV infection during one portion of
the natural history of HPV infections, the replicative cycle.
Our studies do however demonstrate an important dynamic
relationship between two sexually transmitted viruses that
commonly coinfect the human genital track. An increased
understanding of the interaction between HPV and HSV
provides an important addition to our knowledge of how
sexually transmitted agents interact and provides a system
whereby therapeutic interventions can be tested. Addition-
ally, knowledge gained from studies to understand the in-
teraction between HPV and HSV may help us focus on the
portion of the natural history of HPV infections where HSV
can act as a cofactor.
In summary, to our knowledge we have developed the
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first system to study the interaction between HPV and HSV,
two important human pathogens in a system where both
viruses replicate. HSV-1 (KOS) and HSV-2 (186) are both
able to replicate to high titers in HPV-positive host tissue.
The extent of the CPE induced by HSV is dependent on the
magnitude and kinetics of HPV replication and gene expres-
sion at the time of HSV infection. When HPV replication
and gene expression are at high levels, then HSV does not
destroy the tissue but the tissue instead goes through rounds
of high CPE and recovery. During active HSV infection
HPV is able to maintain its replication even when expres-
sion of HPV gene products required for its replication are
repressed, suggesting that HSV may provide the necessary
functions for HPV replication.
Materials and methods
Cell and organotypic cultures
The HPV31b-positive cell line, CIN-612, was estab-
lished from a cervical intraepithelial neoplasia (CIN) type I
biopsy (Bedell et al., 1991). The CIN-612 9E clonal deriv-
ative maintains approximately 50 episomal copies per cell
of the HPV31b genome (Bedell et al., 1991) and is capable
of reproducing the complete HPV life cycle in culture
(Meyers et al., 1992a). CIN-612 9E cells were maintained in
monolayer culture with E medium containing 5% fetal bo-
vine serum (FBS) in the presence of mitomycin C treated J2
3T3 feeder cells (McCance et al., 1988; Meyers, 1996).
Organotypic (raft) CIN-612 9E tissue cultures were grown
as previously described (Meyers, 1996; Meyers et al.,
1992a; Meyers and Laimins, 1994). Briefly, CIN-612 9E
cells were seeded onto collagen matrices containing J2 3T3
fibroblasts. After the CIN-612 9E cells grew to confluence,
collagen matrices were lifted onto stainless steel grids and
the cells were fed by diffusion from under the matrix. Once
lifted to the air–liquid interface, organotypic cultures were
fed with E medium plus 5% FBS. The CIN-612 9E cells
were allowed to stratify and differentiate at the air–liquid
interface.
Infection and titering
HSV infections and titering were done as previously
described (Visalli et al., 1997). Briefly, differentiating or-
ganotypic culture tissues were infected with HSV-1 (KOS
strain) or HSV-2 (186 strain) at different time points after
lifting the organotypic cultures to the air–liquid interface.
Medium was removed from each plate and approximately
102 or 103 PFU in a volume of 0.5 ml was applied and
reapplied to the top of the organotypic tissues four times at
15-min intervals for 1 h. Infected tissues were allowed to
continue to grow for varying lengths of time using E me-
dium plus 5% FBS as before and incubated at 37°C. Mock-
infection was done by applying and reapplying media lack-
ing HSV to the top of the organotypic tissue four times at
15-min intervals for 1 h. Tissues were harvested at various
times and frozen at 80°C. Infected organotypic tissues
were processed for virus titrations by adding 1 ml of me-
dium per culture and sonicating the tissue for 30 s in a
water-filled cup horn sonicator accessory to allow for the
sterile disruption of the differentiated cell layers away from
the collagen matrix. Tissue sonicates were frozen and
thawed three times in a dry ice/ethanol bath for 15 min each.
The 30-s sonication was repeated and the fractured organo-
typic tissues were spun at low speed to pellet the remaining
collagen/cell debris. Aliquots of each organotypic tissue
time point were titered on Vero cells and graphed as total
PFU per infected organotypic culture.
Immunohistochemistry
Stratified and differentiated organotypic culture tissues
derived from HPV31b-positive CIN-612 9E cells were in-
fected with either HSV-1 (KOS) or HSV-2 (186). Tissues
were infected with 102 or 103 PFU of HSV as described
above. Infected organotypic tissues were harvested at vari-
ous times, fixed in 10% buffered formalin, and paraffin-
embedded. Sections of tissue from various time points were
stained with hematoxylin and eosin or immunostained with
an HSV-1 ICP4 polyclonal antibody (Yao and Courtney,
1989) or a monoclonal antibody to the HSV major capsid
polypeptide, VP5 (Advanced Biotechnologies, Columbia,
MD) using the VECTASTAIN Elite ABC Kit (Vector Lab-
oratories, Burlingame, CA) according to the manufacturer’s
instructions.
Nucleic acid extraction
HPV31b viral replication in organotypic raft cultures
was measured by Southern blot analysis. Total cellular
DNA in raft tissue was extracted as previously described
(Ozbun and Meyers, 1998a). Total RNA was extracted from
raft tissues by using TRIzol reagent according to manufac-
turer’s directions (Gibco-BRL, Bethesda, MD). To remove
copurifying viral and cellular DNA, the RNA samples were
treated with DNase I (Ozbun and Meyers, 1996, 1997).
Southern blotting
Five micrograms of total cellular DNA was digested with
XbaI, which linearizes the HPV31b genome at nucleotide
4998, and separated by 0.8% agarose electrophoresis fol-
lowed by transferring to GeneScreen Plus membranes (New
England Nuclear Research Products, Boston, MA), as pre-
viously reported (Ozbun and Meyers, 1996, 1997). A 32P-
labeled total HPV31 genomic DNA probe was generated by
random primer extension and used to probe the membranes
as described (Ozbun and Meyers, 1996, 1997).
52 C. Meyers et al. / Virology 315 (2003) 43–55
RNase protection assays (RPAs)
Antisense RNA probes were synthesized as previously
described (Ozbun and Meyers, 1996, 1997, 1998a, 1998b,
1999b). The E7,E1*I,E2 probe was derived from HPV31b
cDNA clone pCR31b-E7 and is specific to 169 nt of
E7,E1*I,E2 (HPV31 nt 747–877^2646–2683) and 131 nt of
E7, E1 (HPV31 nt 747–877). Probes were purified and
hybridizations were performed as previously reported
(Ozbun and Meyers, 1996, 1997). An antisense E6E7 probe
was synthesized using the pAccI construct (a kind gift from
Laimonis Laimins, Northwestern University College of
Medicine). The 548-bp AccI fragment of HPV31b, corre-
sponding to nt 200–747, was amplified by PCR and sub-
cloned into pBluescript (Hummel et al., 1992). The anti-
sense RNA probe was created by AflIII digestion and by
using the T3 promoter. This RNA probe yielded a 365-nt
probe predicted to protect 325 nt of the HPV31b E6E7
mRNA. Samples were analyzed by electrophoresis through
5% polyacrylamide–7 M urea gels followed by autoradiog-
raphy. RNA Century standards were prepared as per man-
ufacturer’s recommendations (Ambion Inc., Austin, TX).
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